Name | Value |
---|---|
Revenues | 0.0K |
Cost of Revenue | 4,802.0K |
Gross Profit | -4,802.0K |
Operating Expense | 4,746.0K |
Operating I/L | -4,802.0K |
Other Income/Expense | 559.0K |
Interest Income | 31.0K |
Pretax | -4,243.0K |
Income Tax Expense | -1,006.0K |
Net Income/Loss | -3,237.0K |
PolarityTE, Inc. is a clinical stage biotechnology company specializing in regenerative tissue products and biomaterials for medical and material sciences. The company operates in two segments, Regenerative Medicine Products and Contract Services, offering SkinTE for skin repair and reconstruction, as well as contract research services. Additionally, it develops SkinTE Cryo for multiple deployments, a point-of-care device for immediate processing and deployment, and PTE 11000 for wound care and aesthetics. PolarityTE generates revenue through the sale of its regenerative tissue products and contract research services.